CLINICAL ROLE -
EP. 1: Comparison of Biosimilars vs Biologic Agents
Watch
EP. 2: FDA Approval Process of Biosimilars
EP. 3: Interchangeability Status in Biosimilars
EP. 4: Efficacy of Biosimilars vs Biologics
EP. 5: Role of Biosimilars in US vs Europe
EP. 6: Impact of Biosimilars on Cancer Treatment
EP. 7: Currently Available Biosimilars in the US
EP. 8: Current and Next-Generation Biosimilars in Oncology
EP. 9: Clinical Experiences for Biosimilars in Oncology
EP. 10: Biosimilar Decision-Making Process in Clinical Settings
EP. 11: Recommending Biosimilars vs Biologics: Patient Factors
EP. 12: Switching Treatment From Biologics to Biosimilars
EP. 13: Limiting Quantity of Available Biosimilars
EP. 14: Role of Clinical Pharmacists in Switching Biosimilars
EP. 15: Provider Education on Biosimilar Products
EP. 16: Raising Patient Awareness of Biosimilar Products
EP. 17: Myths and Misconceptions on Biosimilars
EP. 18: Economic Impact of Biosimilars
EP. 19: Impact of Competition of Biosimilars on Biologics
